No. 9, Zhuzhou Road; High-tech Dev. Zone, Zhecheng
Shangqiu, Henan, 476 200
People's Republic of China
Melan Group is a comprehensive enterprise group engaged in the research, development, production, sales and service of animal health products. It owns 1 research institution and 4 pharmaceutical industrial parks, covering a total area of over 340,000 m2. It has 54 GMP production lines and its products cover over 400 kinds of biological vaccines, pharmaceutical preparations and feed additives.
Melan Group adheres to the development strategy of "Strengthening the enterprise through science and technology," and has established Melan Group R&D Center. It has more than 10 innovation platforms, including a "National Enterprise Technology Center," a provincial and ministerial-level "Key Laboratory", "Postdoctoral Innovation Practice Base", "Enterprise Technology Center", and "Engineering Technology Research Center". It has carried out technical cooperation with well-known domestic research institutes and has undertaken a number of major provincial and ministerial-level scientific research projects. Its research on the application of traditional Chinese medicine adjuvants has filled the gap in the company's innovative application research. It has reached the leading level in China in veterinary vaccine manufacturing technologies such as cell suspension culture and has achieved industrialization and promotion.
Melan Group is dedicated to safeguarding the health of companion animals and empowering pets to reach new heights in health. With strong independent research and development capabilities and open cooperation strategies, Melan Group's pet sector will focus on the core health challenges of pets (mainly dogs and cats), gradually covering a comprehensive product line of vaccine generic drug technology, antibody interferon application drugs, and nutritional supplements, and creating a pet lifecycle health solution.
Melan Group adheres to the business philosophy of stability, focus, integrity, and innovation. We strive to make high-quality medicines, grow the company into a large and strong enterprise, help our employees become wealthy, provide high-quality products and services to our customers, generate tax revenue for the country, provide employment for society, and build a modern, technology-driven enterprise with first-class standards, thus contributing our due share to the country's economic and social development.